The United States Food and Drug Administration on Saturday approved emergency-use authorisation for a single-dose coronavirus vaccine devel...
The United States Food and Drug Administration on Saturday approved emergency-use authorisation for a single-dose coronavirus vaccine developed by pharmaceuticals company Johnson & Johnson. The vaccine became the third one, after those developed by Pfizer-BioNTech and Moderna, to receive the approval in the US.
“After a thorough analysis of the data, the FDA’s scientists and physicians have determined that the vaccine meets the FDA’s expectations for safety and effectiveness appropriate for the authorization of a vaccine for emergency use (sic),” Peter Marks, the director of the drug regulator’s Center for Biologics Evaluation and Research, said.
FDA Commissioner Janet Woodcock said that the approval will expand the availability of vaccines in the country in the fight against the pandemic.
Today, FDA issued an emergency use authorization (EUA) for the third vaccine for the prevention of #COVID19 caused by SARS-CoV-2. The EUA allows the vaccine to be distributed in the U.S for use in individuals 18 years and older. https://t.co/QooSCJWSX0 pic.twitter.com/MWcCdt5n9U
— U.S. FDA (@US_FDA) February 27, 2021
The authorisation allowed the vaccine to be distributed in the US for use in individuals of 18 years of age or older. Unlike the other two approved vaccines, the Johnson & Johnson vaccine is administered as a single dose.
US President Joe Biden also appreciated the approval granted to the vaccine,...
